Clinical Trial Update: The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture

View source ↗

Summary

This clinical trial studying Claudin 3 biology in primary human mammary epithelial cells sponsored by Hackensack Meridian Health has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Breast Cancer | Status: TERMINATED